Estrogen Receptors as Targets for Drug Development for Breast Cancer, Osteoporosis and Cardiovascular Diseases

E-ISSN： 1873-5576|4|6|483-499

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.4, Iss.6, 2004-09, pp. : 483-499

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nuclear membrane receptors and channels as targets for drug development in cardiovascular diseases

By Bkaily Ghassan Avedanian Levon Jacques Danielle

Canadian Journal of Physiology and Pharmacology, Vol. 87, Iss. 2, 2009-02 ,pp. : 108-119

NRC Research Press

Access to resources Recommend Favorite

Estrogen Receptors as Therapeutic Targets in Breast Cancer

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 3, 2006-02 ,pp. : 181-202

Bentham Science Publishers

Access to resources Recommend Favorite

The potential role of estrogen receptors and the SRC family as targets for the treatment of breast cancer

By Spears Melanie Bartlett John

Expert Opinion on Therapeutic Targets, Vol. 13, Iss. 6, 2009-06 ,pp. : 665-674

Informa Healthcare

Access to resources Recommend Favorite

G-Coupled Protein Receptors and Breast Cancer Progression: Potential Drug Targets

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 3, 2007-03 ,pp. : 245-251

Bentham Science Publishers

Access to resources Recommend Favorite

MicroRNAs as Candidate Drug Targets for Cardiovascular Diseases

Current Drug Targets, Vol. 18, Iss. 4, 2017-02 ,pp. : 463-472

Bentham Science Publishers

Access to resources Recommend Favorite